Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Bullboard Posts
Post by HyunDreamon Jul 08, 2016 5:04pm
139 Views
Post# 25036920

will be good in next week

will be good in next weekThis week, we are so happy that Quebec Ministry has lifted the suspension on the all Copper One's claims on Riviere Dore project. Also, we had new 52 weeks high share price during this week, and we know CUO is undervalued now. Current shareholders do not want to sell their shares as low as under $0.15 cents now and people are keep buying over $0.20 cents. For today's market, it is good sign to hold the share price over $0.20 ($0.21 market closing value). I think next week market will be same pattern as this week. Current shareholders will not sell under $0.17 or $0.18 and new investors will buy over $0.20 and more. I hope we will see another new 52 weeks high (over $0.30) in next week. Hopefully, we will get NR for PP and drilling program, so the share price is going to north. Have a great weekend everyone and see in next week.
Bullboard Posts